Reaching a goal weight on a GLP-1 medication is a huge milestone, and it’s natural to start wondering what comes next — can you come off the medication and keep the results, especially if you’re also exercising regularly and eating well? Here’s what current research and major health organizations say about this in general terms.
Nothing in this article is medical or dosing advice. Whether and how to adjust or stop a GLP-1 medication is a decision to make with your prescribing provider, based on your own health history — this is general education only.
What the research generally shows about stopping
Several published studies have followed people after they discontinued GLP-1 medications like semaglutide. A widely discussed extension of the STEP 1 trial, published in the journal Diabetes, Obesity and Metabolism and summarized by outlets including the National Institutes of Health, found that participants who stopped semaglutide after a year of treatment regained, on average, roughly two-thirds of their prior weight loss within a year of stopping, while those who continued the medication generally maintained or continued to lose weight. This doesn’t mean everyone regains weight after stopping, but it does suggest that for many people, the underlying appetite and metabolic effects of the medication play an ongoing role, and that regain is a common — not rare — outcome without other sustained changes.
The Johns Hopkins Medicine and Mayo Clinic both note that GLP-1 medications work partly by altering appetite-regulating hormones and gut signaling, effects that generally fade once the medication is stopped — which helps explain why lifestyle habits built during treatment become especially important afterward.
Factors that may influence what happens after stopping
- Resistance training and muscle mass. Some research and clinical commentary, including guidance summarized by the Harvard T.H. Chan School of Public Health’s Nutrition Source, points to strength training during GLP-1 treatment as a way to help preserve lean muscle mass, which some clinicians believe may support better weight maintenance afterward — though more research is still needed to fully confirm long-term outcomes.
- Sustainable nutrition habits. Because appetite suppression tends to fade after stopping, habits built around portion awareness and food choices during treatment may matter more once that pharmacological support is gone.
- Gradual, supervised changes. Rather than stopping abruptly on your own schedule, many clinicians favor a supervised approach — discussing timing, monitoring, and any dose adjustments directly with the prescriber — since individual metabolic responses vary considerably.
- Underlying conditions. For people using these medications for type 2 diabetes or other conditions beyond weight management, stopping can have implications well beyond weight, which is another reason this should be a provider-guided decision.
The bottom line
Maintaining weight loss after stopping a GLP-1 medication is possible for some people, but research suggests it’s genuinely difficult without continued attention to the habits — activity, strength training, nutrition — that support metabolic health independent of the drug. If you’re considering stopping or tapering, the safest path is a conversation with your prescriber about a plan tailored to your health history, not a fixed timeline or self-directed schedule.
— Gemifys
